{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:25:47Z","timestamp":1783635947056,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.clnesp.2023.10.001","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T07:30:44Z","timestamp":1696663844000},"page":"221-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Investigation about the correlation between the severity of metabolic-associated fatty liver disease and adherence to the Mediterranean diet"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4869-9442","authenticated-orcid":false,"given":"Marjan","family":"Mokhtare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir M.","family":"Sadeghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7181-2944","authenticated-orcid":false,"given":"Mohammadjavad","family":"Sotoudeheian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Namazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Khalighi Sikaroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2023.10.001_bib1","article-title":"An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD","author":"Lim","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clnesp.2023.10.001_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/20420188221139650","article-title":"Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease","volume":"13","author":"Kaya","year":"2022","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2023.10.001_bib3","year":"2023","journal-title":"TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease. Hepatol forum"},{"key":"10.1016\/j.clnesp.2023.10.001_bib4","article-title":"Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients: what do we know so far?","volume":"85","author":"Binet","year":"2022","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.clnesp.2023.10.001_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231160394","article-title":"Non-pharmacological management options for MAFLD: a practical guide","volume":"14","author":"Stefano","year":"2023","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2023.10.001_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155294","article-title":"Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: a data-driven cluster analysis with international validation","volume":"136","author":"Ye","year":"2022","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.clnesp.2023.10.001_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-022-01659-1","article-title":"Association between the severity of metabolic dysfunction-associated fatty liver disease and the risk of colorectal neoplasm: a systematic review and meta-analysis","volume":"21","author":"Zeng","year":"2022","journal-title":"Lipids Health Dis"},{"issue":"4","key":"10.1016\/j.clnesp.2023.10.001_bib8","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.3390\/ijerph19042096","article-title":"Prevalence and risk factors of metabolic-associated fatty liver disease among 73,566 individuals in Beijing, China","volume":"19","author":"Yuan","year":"2022","journal-title":"Int J Environ Res Publ Health"},{"issue":"6","key":"10.1016\/j.clnesp.2023.10.001_bib9","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"issue":"21","key":"10.1016\/j.clnesp.2023.10.001_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111905","article-title":"Clinical and molecular biomarkers for diagnosis and staging of NAFLD","volume":"22","author":"Di Mauro","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clnesp.2023.10.001_bib11","series-title":"A\u00a014-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: the PREDIMED trial","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2012"},{"issue":"3","key":"10.1016\/j.clnesp.2023.10.001_bib12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/joim.13333","article-title":"The Mediterranean diet and health: a comprehensive overview","volume":"290","author":"Guasch-Ferr\u00e9","year":"2021","journal-title":"J\u00a0Intern Med"},{"issue":"15","key":"10.1016\/j.clnesp.2023.10.001_bib13","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.3390\/nu14153186","article-title":"Adherence to Mediterranean diet and NAFLD in patients with metabolic syndrome: the FLIPAN study","volume":"14","author":"Montemayor","year":"2022","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.clnesp.2023.10.001_bib14","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3390\/antiox11081440","article-title":"Increased adherence to the Mediterranean diet after lifestyle intervention improves oxidative and inflammatory status in patients with non-alcoholic fatty liver disease","volume":"11","author":"Monserrat-Mesquida","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.clnesp.2023.10.001_bib15","first-page":"S23","article-title":"Low adherence to Mediterranean Diet is associated to sCD163 levels in patients with MAFLD","volume":"55","author":"Perez-Diaz-del-Campo","year":"2023","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.clnesp.2023.10.001_bib16","first-page":"39","article-title":"Reliability and validity of the 14-item Mediterranean diet adherence screener among the healthy Iranian population","volume":"27","author":"Sikaroudi","year":"2022","journal-title":"GOVARESH"},{"issue":"5","key":"10.1016\/j.clnesp.2023.10.001_bib17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/hepr.13706","article-title":"MAFLD: renovation of clinical practice and disease awareness of fatty liver","volume":"52","author":"Kawaguchi","year":"2022","journal-title":"Hepatol Res"},{"issue":"4","key":"10.1016\/j.clnesp.2023.10.001_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/reports5040042","article-title":"The extent of insulin resistance in patients that cleared viral hepatitis C infection and the role of pre-existent type 2 diabetes mellitus: a meta-analysis","volume":"5","author":"Popescu","year":"2022","journal-title":"Reports"},{"issue":"1","key":"10.1016\/j.clnesp.2023.10.001_bib19","first-page":"1","article-title":"Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study","volume":"11","author":"Ye","year":"2019","journal-title":"Diab Metab Syndr"},{"issue":"3","key":"10.1016\/j.clnesp.2023.10.001_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1207\/s15327906mbr2603_7","article-title":"How many subjects does it take to do a regression analysis","volume":"26","author":"Green","year":"1991","journal-title":"Multivariate Behav Res"},{"issue":"2","key":"10.1016\/j.clnesp.2023.10.001_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jfma.2021.07.013","article-title":"The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: a diagnostic or screening tool?","volume":"121","author":"Xu","year":"2022","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.clnesp.2023.10.001_bib22","series-title":"The role of FibroScan in the era of metabolic (dysfunction)-associated fatty liver disease","year":"2023"},{"issue":"4","key":"10.1016\/j.clnesp.2023.10.001_bib23","first-page":"242","article-title":"Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"7","author":"Hashemi","year":"2016","journal-title":"Casp J Intern Med"},{"issue":"1","key":"10.1016\/j.clnesp.2023.10.001_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-021-01612-z","article-title":"Dietary patterns and risk of non-alcoholic fatty liver disease","volume":"21","author":"Salehi-Sahlabadi","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clnesp.2023.10.001_bib25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1590\/s0004-2803.201900000-67","article-title":"Impact of current diet at the risk of non-alcoholic fatty liver disease (NAFLD)","volume":"56","author":"Duarte","year":"2019","journal-title":"Arq Gastroenterol"},{"issue":"21","key":"10.1016\/j.clnesp.2023.10.001_bib26","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.3390\/nu14214559","article-title":"Inverse association of fruit and vegetable consumption with nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus","volume":"14","author":"Du","year":"2022","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.clnesp.2023.10.001_bib27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/17474124.2019.1634544","article-title":"Olive oil antioxidants and non-alcoholic fatty liver disease","volume":"13","author":"Abenavoli","year":"2019","journal-title":"Expet Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clnesp.2023.10.001_bib28","article-title":"Relationship between vitamin D deficiency and non-alcoholic fatty liver disease: a cross-sectional study from a tertiary care center in Northern India","volume":"15","author":"Kumar","year":"2023","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.clnesp.2023.10.001_bib29","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.3390\/nu14122367","article-title":"Exploring the path of Mediterranean diet, non-alcoholic fatty liver disease (NAFLD) and inflammation towards 10-year cardiovascular disease (CVD) risk: the ATTICA study 10-year follow-up (2002\u20132012)","volume":"14","author":"George","year":"2022","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.clnesp.2023.10.001_bib30","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1002\/ptr.6791","article-title":"The effect of saffron supplementation on some inflammatory and oxidative markers, leptin, adiponectin, and body composition in patients with nonalcoholic fatty liver disease: a double-blind randomized clinical trial","volume":"34","author":"Kavianipour","year":"2020","journal-title":"Phytother Res"},{"key":"10.1016\/j.clnesp.2023.10.001_bib31","doi-asserted-by":"crossref","first-page":"100832","DOI":"10.1016\/j.aohep.2022.100832","article-title":"Mediterranean diet vs. regional diet in a Mexican population with MAFLD: 3-month cohort","volume":"27","author":"Garc\u00eda-Carvajal","year":"2022","journal-title":"Ann Hepatol"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457723021587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457723021587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T01:04:50Z","timestamp":1719363890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457723021587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":31,"alternative-id":["S2405457723021587"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2023.10.001","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation about the correlation between the severity of metabolic-associated fatty liver disease and adherence to the Mediterranean diet","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2023.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}